S100A11 is overexpressed in several cancers and suggested to act either as tumor suppressor (in bladder and renal carcinoma) or oncogene (in prostate, breast and pancreatic cancer) [38]. This evidence concerns the gene S100A11 and pancreatic neoplasm.